GLP-1 RA Improves Diabetic Retinopathy by Protecting the Blood-Retinal Barrier through GLP-1R-ROCK-p-MLC Signaling Pathway

BACKGROUND: GLP-1 receptor agonists (GLP-1RA) are common clinical agents that are clinically protective against diabetic complications, such as diabetic retinopathy (DR). Previous studies have shown that the RhoA/ROCK pathway plays an important role in the development of DR. However, the specific me...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Liufeng, Mo, Weiwei, Lan, Shanshan, Yang, Haiyan, Huang, Zhenxing, Liang, Xinghuan, Li, Li, Xian, Jing, Xie, Xuemei, Qin, Yingfen, Lin, Faquan, Luo, Zuojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649324/
https://www.ncbi.nlm.nih.gov/pubmed/36387940
http://dx.doi.org/10.1155/2022/1861940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649324/
https://www.ncbi.nlm.nih.gov/pubmed/36387940
http://dx.doi.org/10.1155/2022/1861940

Ejemplares similares